Asia Green Biotechnology (ASIA.CN) Action Cours

Asia Green Biotechnology Corp. is an early stage international agri-technology company, which engages in the development, evaluation, testing, application, and supply to the market of proprietary organic hybridization technology. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-01-24. The firm is focused on the development, evaluation, testing, application and, ultimately, supply to the market of organic hybridization technology and certain products derived from that technology (the Technology). The firm is engaged in planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities under the terms of the license agreement with InPlanta Biotechnology Inc. (InPlanta) and the evaluation and development of medicinal and related cannabinoid extracts under the terms of license agreements with Swysh Inc. (Swysh), and Pathway Rx Corp (Pathway Rx). The company is in the process of establishing and implementing research and development programs in Cambodia and Thailand and continues to evaluate the potential to expand its business operations to other countries in the region.